Similar Search Results

Narrow search

[Rezension von: Pharmaceutical innovation: revolutionizing human health, ed. by Ralph Landau ...]

Comanor, William S. - In: Journal of economic literature 39 (2001) 3, pp. 944-945

Persistent link: https://www.econbiz.de/10001612430

Pharmaceutical markets in Japan and the United States

Comanor, William S. - In: International journal of economic policy studies 16 (2022) 2, pp. 355-370

Persistent link: https://www.econbiz.de/10013433326

Mergers and innovation in the pharmaceutical market

Comanor, William S.; Scherer, Frederic M. - 2011

Persistent link: https://www.econbiz.de/10009487486

Mergers and innovation in the pharmaceutical industry

Comanor, William S.; Scherer, Frederic M. - In: Journal of health economics 32 (2013) 1, pp. 106-113

Persistent link: https://www.econbiz.de/10009703553

Strategic pricing of new pharmaceuticals

Lu, Z. John - In: The review of economics and statistics 80 (1998) 1, pp. 108-118

Persistent link: https://www.econbiz.de/10001235776

U.S. pharmaceutical markets : expenditures, health insurance, new products and generic prescribing from 1960 to 2016

Lu, Z. John; Comanor, William S.; Cherkas, Elliot; … - In: International journal of the economics of business 27 (2020) 1, pp. 1-26

Persistent link: https://www.econbiz.de/10012182277

Mergers and Innovation in the Pharmaceutical Industry

Comanor, William S. - 2012

Conflicting trends confound the pharmaceutical industry. The productivity of pharmaceutical innovation has declined in recent years. At the same time, the cohort of large companies who are the leading engines of pharmaceutical R&D has become increasingly concentrated. The concurrent presence of...

Persistent link: https://www.econbiz.de/10013096412

Mergers and innovation in the pharmaceutical industry

Comanor, William S.; Scherer, F.M. - In: Journal of Health Economics 32 (2013) 1, pp. 106-113

Persistent link: https://www.econbiz.de/10010870797